News
IVBXF
12.00
NaN%
--
Nuvation Bio rises on FDA label update for Ibtrozi
Seeking Alpha · 13h ago
Analysts Offer Insights on Healthcare Companies: Innovent Biologics (OtherIVBXF) and Definium Therapeutics (DFTX)
TipRanks · 3d ago
Huatai Securities Sticks to Their Buy Rating for Innovent Biologics (IVBXF)
TipRanks · 4d ago
UBS Keeps Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks · 09/04 00:26
BOCOM International Holdings Company Reaffirms Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks · 09/03 05:06
Innovent Biologics Details Board and Committee Structure
TipRanks · 09/01 12:38
Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)
TipRanks · 08/30 09:01
Jefferies Remains a Buy on Innovent Biologics (IVBXF)
TipRanks · 08/27 12:17
Innovent Biologics (IVBXF) Receives a Buy from Citi
TipRanks · 08/27 11:16
Analyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
TipRanks · 08/27 07:15
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
TipRanks · 08/26 10:35
Sinolink Securities Sticks to Its Buy Rating for Innovent Biologics (IVBXF)
TipRanks · 08/26 05:18
CICC Remains a Buy on Innovent Biologics (IVBXF)
TipRanks · 08/26 05:17
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nanosonics Limited (OtherNNCSF) and Innovent Biologics (OtherIVBXF)
TipRanks · 08/26 01:40
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
TipRanks · 08/25 10:38
Innovent Biologics Delivers Strong First-Half 2026 Profit and Revenue Surge
TipRanks · 08/25 10:07
Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular Diagnostics (IMDX) and Innovent Biologics (OtherIVBXF)
TipRanks · 08/18 14:40
Innovent Biologics (IVBXF) Receives a Buy from Daiwa
TipRanks · 08/14 00:27
Innovent Biologics Sets Board Meeting to Approve 2026 Interim Results
TipRanks · 08/10 09:11
Daiichi Sankyo, Innovent enter exclusive agreement for Vanflyta in China
TipRanks · 08/10 00:35
More
Webull provides a variety of real-time IVBXF stock news. You can receive the latest news about Innovent Biologi through multiple platforms. This information may help you make smarter investment decisions.
About IVBXF
Innovent Biologics Inc is an investment holding company principally engaged in the research, development, production and sales of innovative medicines for the treatment of diseases such as cancer, cardiovascular and metabolic (CVM), autoimmune and eye diseases. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The Company mainly conducts its businesses within domestic and overseas markets.